Skip to main content
. 2017 Apr 11;8(21):35069–35075. doi: 10.18632/oncotarget.17047

Figure 1. IR700 fluorescence real-time imaging in MDA-MB468luc tumors and A431luc tumors.

Figure 1

(A) Treatment schedule demonstrating the regimen of NIR-PIT with multiple NIR light exposures. (B, C) IR700 fluorescence real-time imaging in MDA-MB468luc tumors (B) and A431luc tumors (C). The distribution of Pan-IR700 is demonstrated.